Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Warrick Albuterol Medicaid "Overpayments" Total $14.6 Mil. -Texas Argues

Executive Summary

Warrick Pharmaceuticals is responsible for $14.6 mil. in albuterol reimbursement overpayments made by the Texas Medicaid Program, Texas Attorney General John Cornyn argued in a lawsuit filed Sept. 7 in Travis County, Texas state court.

You may also be interested in...



Dey will pay

Dey settles Medicaid fraud claims with U.S. and Texas and agrees to pay $18.5 mil. over charges of submitting false pricing information. Cases against Schering-Plough subsidiary Warrick and Boehringer Ingelheim subsidiary Roxane are scheduled to go to trial in August. The suits were based on information from a whistleblower (1"The Pink Sheet" Sept. 11, 2000, p. 10)...

Dey will pay

Dey settles Medicaid fraud claims with U.S. and Texas and agrees to pay $18.5 mil. over charges of submitting false pricing information. Cases against Schering-Plough subsidiary Warrick and Boehringer Ingelheim subsidiary Roxane are scheduled to go to trial in August. The suits were based on information from a whistleblower (1"The Pink Sheet" Sept. 11, 2000, p. 10)...

Schering GMPs Linger: Whistleblower Suit Filed, Consent Decree Extended

Schering-Plough has been named in a False Claims Act suit alleging the company (and two dozen other manufacturers) knowingly sold adulterated products to the federal government

Related Content

UsernamePublicRestriction

Register

LL005491

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel